Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
---|---|---|---|---|---|
ILT-M5252 | Mouse | Mouse gp130 / CD130 / IL-6 R beta Protein, Fc Tag |
|
||
ILT-M52H1 | Mouse | Mouse gp130 / CD130 / IL-6 R beta Protein, His Tag |
|
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Sarilumab | REGN-88; SAR-153191 | Approved | Sanofi, Regeneron Pharmaceuticals Inc | Kevzara | Japan | Arthritis, Rheumatoid | Sanofi | 2017-05-22 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Coronavirus Disease 2019 (COVID-19); Sarcoidosis; Mastocytosis, Systemic; Arthritis, Juvenile; Coronavirus Infections; Severe Acute Respiratory Syndrome; Uveitis | Details |
Satralizumab | RG-6168; SA-237 | Approved | Chugai Pharmaceutical Co Ltd | Enspryng, エンスプリング | EU | Neuromyelitis Optica | Roche Registration Gmbh | 2020-06-29 | Myasthenia Gravis; Neuromyelitis Optica; Anti-N-Methyl-D-Aspartate Receptor Encephalitis | Details |
Tocilizumab | R-1569; rhPM-1; RG-1569; RO-48775533; MRA; HPM-1; MRA-SC | Approved | Chugai Pharmaceutical Co Ltd | Actemra, RoActemra, Actemra/RoActemra, 雅美罗 | EU | Coronavirus Disease 2019 (COVID-19) | Roche Registration Gmbh | 2005-04-11 | Pulmonary Disease, Chronic Obstructive; Stroke; Graves Ophthalmopathy; Coronavirus Infections; Coronary Disease; Takayasu Arteritis; Multicentric Castleman's Disease (MCD); Severe Acute Respiratory Syndrome; Lupus Erythematosus, Systemic; systemic sclerosis-associated interstitial lung disease; Pulmonary Arterial Hypertension; Breast Neoplasms; Fever; Respiratory Distress Syndrome, Adult; Uveitis, Posterior; Inflammation; Uveitis; Lymphoma; Osteoarthritis; Rejection in heart transplantation; Carcinoma, Hepatocellular; Non-ST Elevated Myocardial Infarction; Amyotrophic Lateral Sclerosis; Behcet Syndrome; Diabetes Mellitus; Kidney Failure, Chronic; Depressive Disorder, Major; Diabetes Mellitus, Type 1; Hematologic Neoplasms; Solid tumours; Motor Neuron Disease; Craniopharyngioma; Polymyositis; HIV Infections; Uveitis, Intermediate; Myocardial Infarction; Giant Cell Arteritis; Schnitzler Syndrome; Pneumonia; Cytokine Release Syndrome; Dermatomyositis; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheum | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Tocilizumab biosimilar (AryoGen Pharmed) | Phase 3 Clinical | Aryogen Biopharma | Arthritis, Rheumatoid | Details | |
CMAB806 | CMAB-806 | Phase 3 Clinical | Taizhou Maibo Taike Biotechnology Co Ltd | Arthritis, Rheumatoid; Arthritis | Details |
Recombinant humanized anti-IL-6R antibody (Hisun Pharma) | HS-628 | Phase 3 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Arthritis, Rheumatoid; Arthritis | Details |
Levilimab | BCD-089 | Phase 3 Clinical | Biocad | Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid | Details |
VDJ-001 | Phase 2 Clinical | Beijing Vdjbio Co Ltd | Arthritis, Rheumatoid; Multicentric Castleman's Disease (MCD) | Details | |
Olamkicept | TJ-301; FE-999301; CR-5/18; FE-301 | Phase 2 Clinical | Conaris Research Institute | Colitis, Ulcerative | Details |
Tocilizumab biosimilar (Fresenius kabi) | MSB-11456 | Phase 3 Clinical | Merck Serono | Arthritis, Rheumatoid | Details |
Atexakin alfa | SON-080; r-IL-6 | Phase 2 Clinical | Merck Serono, Weizmann Institute Of Science | Peripheral Nervous System Diseases; Diabetic Neuropathies | Details |
Tocilizumab biosimilar (Celltrion) | CT-P47; CT-P-47 | Phase 3 Clinical | Celltrion Inc | Arthritis, Rheumatoid | Details |
This web search service is supported by Google Inc.